Followers | 19 |
Posts | 6384 |
Boards Moderated | 2 |
Alias Born | 05/23/2019 |

Friday, May 09, 2025 1:20:58 AM
Trump nominates Dr Casey Means, influencer close to RFK Jr, for surgeon general
President taps wellness influencer after withdrawing initial pick, former Fox News contributor Janette Nesheiwat
Wed 7 May 2025 19.56 EDT
“Donald Trump has tapped Dr Casey Means, a wellness influencer with close ties to Robert F Kennedy Jr, the US health secretary, as nominee for surgeon general after withdrawing his initial pick for the influential health post.”
“Casey Means has no government experience and dropped out of her surgical residency program, saying she became disillusioned with traditional medicine. She founded a health tech company, Levels, that helps users track blood sugar and other metrics. She also makes money from dietary supplements, creams, teas and other products sponsored on her social media accounts.“
https://www.theguardian.com/us-news/2025/may/07/trump-surgeon-general-nominee-casey-means
https://www.caseymeans.com/
“ Dr. Casey Means, a wellness influencer and medical doctor, has been nominated by President Donald Trump to serve as the new Surgeon General, replacing Janette Nesheiwat. Means, who is known for her work in functional medicine and metabolic health, has been criticized for her inactive medical license and her promotion of holistic health approaches over traditional medical practices.
Dr. Casey Means: An American medical doctor, entrepreneur, and author known for her work in functional medicine and metabolic health. She co-founded Levels, a company that offers continuous glucose monitors, and wrote the book "Good Energy" with her brother Calley Means.
Dr. Means has been vocal about her views on health and wellness, often advocating for holistic and natural approaches to health. However, her nomination has sparked debate due to her inactive medical license and her past statements questioning the efficacy of certain medical practices, such as vaccines.”

Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2025 09:03:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2025 01:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:28:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:27:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:27:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2025 10:04:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2024 09:17:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 09:38:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:06:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 02:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:54:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:28:43 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM